Keyphrases
Macrophages
100%
Inflammation
100%
MRNA Nanoparticles
100%
Plaque Inflammation
100%
RNA Therapeutics
66%
Clinical Application
33%
Atherosclerotic Lesions
33%
Cardiovascular Disease
33%
Management Approach
33%
Oxidative Stress
33%
Inflammatory Response
33%
Successful Delivery
33%
Therapeutic Approaches
33%
Multiple Events
33%
Major Contributor
33%
Arterial Wall
33%
Lipoproteins
33%
Current Therapies
33%
Plaque
33%
Low-density Lipoprotein Receptor
33%
Inflammation Regulation
33%
Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9)
33%
Atherosclerotic Plaque
33%
Intravenous Administration
33%
Common Pathology
33%
Lipid Deposition
33%
Major Adverse Cardiovascular Events
33%
Atherosclerosis Prevention
33%
Atherosclerosis Progression
33%
Low-density Lipoprotein Cholesterol Level
33%
IL-10 Production
33%
Macrophage Apoptosis
33%
IL-10 mRNA
33%
M2-like
33%
Lesional Macrophage
33%
Necrotic Lesion
33%
Western Diet
33%
Serine Protease
33%
Advanced Atherosclerosis
33%
Cap Thickness
33%
Statins
33%
Pathological Progression
33%
Medicine and Dentistry
Nanoparticle
100%
Atherosclerosis
100%
Macrophage
71%
Cardiovascular Disease
28%
Programmed Cell Death
14%
Serositis
14%
Oxidative Stress
14%
Serine Proteinase
14%
Western Diet
14%
Statin
14%
Lipid Storage
14%
Lipoprotein
14%
Low Density Lipoprotein Cholesterol
14%
Artery Wall
14%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Atherosclerosis
100%
Inflammation
100%
Cardiovascular Disease
28%
Mouse
14%
Lipoprotein
14%
Low Density Lipoprotein Cholesterol
14%
Serine Proteinase
14%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
14%